NEW YORK (GenomeWeb News) - The US Food and Drug Administration’s National Center for Toxicological Research will use Genedata’s biomarker-discovery software, the company said today.
The NCTR’s Center for Toxicoinformatics will use the company’s Expressionist software to support the “vast quantities and varied sources of microarray data” used in its voluntary genomics data submission program.
The software is used for biomarker research involving transcriptomics, proteomics, and metabolomics data, Genedata said.
Genedata’s managing director, Jens Hoefkens, said the agreement will ensure that its customers will be using the same tools as the FDA to identify markers.
Financial terms of the agreement were not released.